Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05763043
EARLY_PHASE1
Monoferric for Prenatal Iron Deficiency
Sponsor: Oregon Health and Science University
View on ClinicalTrials.gov
Summary
A prospective observational study of pregnant women with iron deficiency anemia and oral iron intolerance or advanced gestational age.
Key Details
Gender
FEMALE
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2024-01-18
Completion Date
2028-10
Last Updated
2024-09-19
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Ferric derisomaltose
Participants between the gestational ages of 14 to 42 weeks with iron deficiency will receive IV Ferric derisomaltose at a routine prenatal visit.
Locations (1)
Oregon Health & Science Univerity
Portland, Oregon, United States